Insmed Inc’s recent filing unveils that its Former Officer Wise John Drayton acquired Company’s shares for reported $0.44 million on Jun 13 ’25. In the deal valued at $98.01 per share,4,486 shares were bought.
Then, Flammer Martina M.D. sold 25,740 shares, generating $2,281,594 in total proceeds. Upon selling the shares at $88.64, the Chief Medical Officer now owns 83,111 shares.
Before that, Flammer Martina M.D. sold 19,423 shares. Insmed Inc shares valued at $1,835,474 were divested by the Chief Medical Officer at a price of $94.50 per share. As a result of the transaction, Flammer Martina M.D. now holds 83,111 shares, worth roughly $8.21 million.
Jefferies initiated its Insmed Inc [INSM] rating to a Buy in a research note published on May 13, 2025; the price target was $105. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late February with a ‘”an Outperform”‘ rating. Truist began covering INSM with “Buy” recommendation on April 23, 2024. Wolfe Research started covering the stock on February 15, 2024. It rated INSM as “an Outperform”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock jump 1.91% to $98.73. Over the last five days, the stock has gained 34.11%. Insmed Inc shares have risen nearly 43.00% since the year began. Nevertheless, the stocks have risen 59.58% over the past one year. While a 52-week high of $100.00 was reached on 06/12/25, a 52-week low of $60.40 was recorded on 04/09/25.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 96.61, which if violated will result in even more drops to 94.49. On the upside, there is a resistance level at 100.25. A further resistance level may holdings at 101.77.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-05-30, growing by 1.68 million shares to a total of 17.46 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 15.78 million shares. There was a rise of 9.62%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 08, 2023 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $55 price target.
